Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations

RBC Capital initiated coverage on Shell Midstream Partners LP (NYSE: SHLX) with a Outperform rating and a $47 price target. Shell Midstream Partners shares have dropped 9.10 percent over the past 52 weeks, while the S&P 500 index has declined 2.04 percent in the same period. Shell Midstream Partners gained 0.05 percent to close at $37.77 on Friday.

Wells Fargo initiated coverage on Banc of California Inc (NYSE: BANC) with a Outperform rating. Banc of California shares have surged 58.98 percent over the past 52 weeks, while the S&P 500 index has dropped 2.04 percent in the same period. Banc of California closed at $20.35 on Friday.

Analysts at UBS initiated coverage on Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) with a Buy rating. Aeglea Bio Therapeutics closed at $8.76 on Friday.

Analysts at Goldman Sachs initiated coverage on Dr.Reddy's Laboratories Ltd (ADR) (NYSE: RDY) with a Neutral rating. Dr.Reddy's shares have tumbled 14.67 percent over the past 52 weeks, while the S&P 500 index has slipped 2.04 percent in the same period. Dr.Reddy's Laboratories shares closed at $45.60 on Friday.

Latest Ratings for SHLX

DateFirmActionFromTo
Sep 2019MaintainsBuy
Aug 2019DowngradesNeutralUnderweight
Jul 2019DowngradesNeutralUnderperform

View More Analyst Ratings for SHLX
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (BANC + AGLE)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
SWKSCascendReiterates100.0
IBMWells FargoMaintains140.0
PNCWells FargoMaintains147.0
TWOUDA DavidsonMaintains17.0
IDYAOppenheimerInitiates Coverage On17.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Oppenheimer Reiterates Outperform, $35 Target On FireEye, Sees Positive Momentum As Intact

Costco Shares Higher As JPMorgan Adds To Focus List